“…A variety of in situ amplification approaches have been developed, including immunological methods (Macechko et al, 1997;Hughes and Krause, 1998;Kosman et al, 2004), branched DNA methods (Player et al, 2001;Wang et al, 2012;Kishi et al, 2019;Saka et al, 2019), in situ PCR methods (Nuovo et al, 1992;Martínez et al, 1995;Wiedorn et al, 1999) and rolling circle amplification methods (Gusev et al, 2001;Zhou et al, 2001;Larsson et al, 2010). However, for both RNA-ISH (Tautz and Pfeifle, 1989;Harland, 1991;Lehmann and Tautz, 1994;Kerstens et al, 1995;Nieto et al, 1996;Thisse et al, 2004;Piette et al, 2008;Thisse and Thisse, 2008;Wang et al, 2012) and IHC (Takakura et al, 1997;Sillitoe and Hawkes, 2002;Ahnfelt-Ronne et al, 2007;Fujisawa et al, 2015;Staudt et al, 2015), traditional in situ amplification based on enzyme-mediated catalytic reporter deposition (CARD) remains the dominant approach for achieving high signal-to-background in highly autofluorescent samples, including whole-mount vertebrate embryos and FFPE tissue sections. CARD is widely used despite three significant drawbacks: multiplexing is cumbersome due to the lack of orthogonal deposition chemistries, necessitating serial amplification for one target after another (Denkers et al, 2004;Kosman et al, 2004;Clay and Ramakrishnan, 2005;Barroso-Chinea et al, 2007;Tóth and Mezey, 2007;Glass et al, 2009;Stack et al, 2014;Mitchell et al...…”